文献速递前列腺癌

hsa-miR-125a-3p通过调控转移相关蛋白1信号调节前列腺癌细胞对多西他赛的敏感性

Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling.
PubMed 文献 · Urology · 2017-01-11

本研究探讨hsa-miR-125a-3p在前列腺癌化疗耐药中的作用及其下游靶点。结果显示该miRNA在耐药组织和细胞中显著下调,抑制它增加PC-3细胞对多西他赛耐药,上调它则降低PC-3R细胞耐药,机制上通过调控MTA1诱导凋亡和化疗敏感性。

要点

  • hsa-miR-125a-3p在耐药前列腺癌组织和细胞中显著下调。
  • 抑制hsa-miR-125a-3p增加PC-3细胞对多西他赛耐药,上调则降低PC-3R细胞耐药。
  • hsa-miR-125a-3p通过调控MTA1诱导前列腺癌细胞凋亡和多西他赛敏感性。

核心结论

  • miRNA-MTA1可形成精细调控环路维持多西他赛化疗敏感性的双稳态。
  • 作者认为未来研究应通过调控MTA1功能状态开发基于miRNA的疗法使晚期前列腺癌患者获益。

研究设计与样本

  • 实验研究:在化疗耐药前列腺癌组织和实验建立的耐药细胞中采用定量逆转录聚合酶链反应评估hsa-miR-125a-3p表达。
  • 在化疗敏感的PC-3细胞或化疗耐药的PC-3R细胞中,用凋亡ELISA评估hsa-miR-125a-3p敲低或过表达对多西他赛诱导细胞死亡的影响。
  • 采用多种实验在分子和功能水平研究hsa-miR-125a-3p对转移相关蛋白1(MTA1)的调控。

主要发现

  • hsa-miR-125a-3p在化疗耐药前列腺癌组织和细胞中表达显著下调。
  • 抑制hsa-miR-125a-3p显著增加PC-3细胞对多西他赛的耐药。
  • 上调hsa-miR-125a-3p有效降低PC-3R细胞对多西他赛的耐药。
  • hsa-miR-125a-3p通过调控MTA1诱导前列腺癌细胞凋亡和多西他赛敏感性。

关键数值与推荐

  • hsa-miR-125a-3p在耐药前列腺癌组织和细胞中显著下调。
  • 抑制hsa-miR-125a-3p增加PC-3细胞多西他赛耐药,上调hsa-miR-125a-3p降低PC-3R细胞多西他赛耐药。
  • hsa-miR-125a-3p通过调控MTA1诱导凋亡和多西他赛敏感性。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the potential downstream targets of hsa-miR-125a-3p, a mature form of miR-125a, during the pathogenesis of chemoresistance in prostate cancer (PCa). MATERIALS AND METHODS: The expression levels of hsa-miR-125a-3p were assessed in chemoresistant PCa tissues and experimentally established chemoresistant cells using quantitative reverse transcription-polymerase chain reaction. The effect of hsa-miR-125a-3p knockdown or hsa-miR-125a-3p overexpression on the Dox-induced cell death was evaluated using apoptosis ELISA in chemosensitive PC-3 cells or in chemoresistant PC-3 cells (PC-3R). Finally, using multiple assays, the regulation of metastasis-associated protein 1 (MTA1), an essential component of the Mi-2-nucleosome remodeling deacetylation complex, by hsa-miR-125a-3p was studied at both molecular and functional levels. RESULTS: The expression of hsa-miR-125a-3p was significantly downregulated in chemoresistant PCa tissues and cells. Inhibition of hsa-miR-125a-3p significantly increased docetaxel (Dox) resistance in PC-3 cells, whereas upregulation of hsa-miR-125a-3p effectively reduced Dox resistance in PC-3R, suggesting that this microRNA (miRNA) may act as a tumor suppressor along the pathogenesis of drug resistance. Mechanistically, hsa-miR-125a-3p induced apoptosis and Dox sensitivity in PCa cells through regulating MTA1. CONCLUSION: Our results collectively indicate that miRNA-MTA1 can form a delicate regulatory loop to maintain a bistable state in the Dox chemosensitivity, and future endeavor in this filed should provide important clues to develop miRNA-based therapies that benefit advanced PCa patients through modulating the functional status of MTA1.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Liu JZ, Yin FY, Yan CY, et al. Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling. Urology. 2017. PMID: 28088556. doi:10.1016/j.urology.2017.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。